☰

Isabel D. Markl, Ph.D. - Publications

Affiliations: 
2006 University of Southern California, Los Angeles, CA, United States 
Area:
DNA methylation, cancer, epigenetics
Tree Info Grants Similar researchers PubMed Report error

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2001 Markl ID, Cheng J, Liang G, Shibata D, Laird PW, Jones PA. Global and gene-specific epigenetic patterns in human bladder cancer genomes are relatively stable in vivo and in vitro over time. Cancer Research. 61: 5875-84. PMID 11479229  0.388
2000 Tsao JL, Yatabe Y, Markl ID, Hajyan K, Jones PA, Shibata D. Bladder cancer genotype stability during clinical progression. Genes, Chromosomes & Cancer. 29: 26-32. PMID 10918390 DOI: 10.1002/1098-2264(2000)9999:9999<::Aid-Gcc1002>3.0.Co;2-X  0.449
2000 Salem CE, Markl ID, Bender CM, Gonzales FA, Jones PA, Liang G. PAX6 methylation and ectopic expression in human tumor cells. International Journal of Cancer. Journal International Du Cancer. 87: 179-85. PMID 10861471 DOI: 10.1002/1097-0215(20000715)87:2<179::Aid-Ijc4>3.0.Co;2-X  0.577
1998 Markl ID, Jones PA. Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer. Cancer Research. 58: 5348-53. PMID 9850064  0.46
1998 Walker GJ, Flores JF, Glendening JM, Lin AH, Markl ID, Fountain JW. Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets. Genes, Chromosomes & Cancer. 22: 157-63. PMID 9598804 DOI: 10.1002/(SICI)1098-2264(199806)22:2<157::AID-GCC11>3.0.CO;2-N  0.303
Show low-probability matches.